Literature DB >> 29212831

Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.

Helen Christou1, Hannes Hudalla1, Zoe Michael1, Evgenia J Filatava1, Jun Li1, Minglin Zhu1, Jose S Possomato-Vieira1, Carlos Dias-Junior1, Stella Kourembanas1, Raouf A Khalil2.   

Abstract

Pulmonary vasoreactivity could determine the responsiveness to vasodilators and, in turn, the prognosis of pulmonary hypertension (PH). We hypothesized that pulmonary vasoreactivity is impaired, and we examined the underlying mechanisms in the Sugen-hypoxia rat model of severe PH. Male Sprague-Dawley rats were injected with Sugen (20 mg/kg s.c.) and exposed to hypoxia (9% O2) for 3 weeks, followed by 4 weeks in normoxia (Su/Hx), or treated with Sugen alone (Su) or hypoxia alone (Hx) or neither (Nx). After hemodynamic measurements, the heart was assessed for right ventricular hypertrophy (Fulton's index); the pulmonary artery, aorta, and mesenteric arteries were isolated for vascular function studies; and contractile markers were measured in pulmonary arteries using quantitative polymerase chain reaction (PCR). Other rats were used for morphometric analysis of pulmonary vascular remodeling. Right ventricular systolic pressure and Fulton's index were higher in Su/Hx versus Su, Hx, and Nx rats. Pulmonary vascular remodeling was more prominent in Su/Hx versus Nx rats. In pulmonary artery rings, contraction to high KCl (96 mM) was less in Su/Hx versus Nx and Su, and phenylephrine-induced contraction was reduced in Su/Hx versus Nx, Hx, and Su. Acetylcholine (ACh)-induced relaxation was less in Su/Hx versus Nx and Hx, suggesting reduced endothelium-dependent vasodilation. ACh relaxation was inhibited by nitric oxide synthase (NOS) and guanylate cyclase blockade in all groups, suggesting a role of the NO-cGMP pathway. Nitrate/nitrite production in response to ACh was less in Su/Hx versus Nx, supporting reduced endothelial NO production. Sodium nitroprusside (10-8 M) caused less relaxation in Su/Hx versus Nx, Hx, and Su, suggesting a decreased responsiveness of vascular smooth muscle (VSM) to vasodilators. Neither contraction nor relaxation differed in the aorta or mesenteric arteries of all groups. PCR analysis showed decreased expression of contractile markers in pulmonary artery of Su/Hx versus Nx. The reduced responsiveness to vasoconstrictors and NO-mediated vasodilation in the pulmonary, but not systemic, vessels may be an underlying mechanism of severe PH in Su/Hx rats and appears to involve attenuation of the NO relaxation pathway and a switch of pulmonary VSM cells to a synthetic less reactive phenotype.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29212831      PMCID: PMC5774216          DOI: 10.1124/jpet.117.244798

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  71 in total

1.  Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension.

Authors:  Robert J Aiello; Patricia-Ann Bourassa; Qing Zhang; Jeffrey Dubins; Daniel R Goldberg; Stéphane De Lombaert; Marc Humbert; Christophe Guignabert; Maria A Cavasin; Timothy A McKinsey; Vishwas Paralkar
Journal:  J Pharmacol Exp Ther       Date:  2016-12-07       Impact factor: 4.030

Review 2.  Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension.

Authors:  Daisy A Salamanca; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2005-09-01       Impact factor: 5.858

Review 3.  Altered pulmonary vasoreactivity in the chronically hypoxic lung.

Authors:  L A Shimoda; J S Sham; J T Sylvester
Journal:  Physiol Res       Date:  2000       Impact factor: 1.881

4.  Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.

Authors:  M Sean McMurtry; Stephen L Archer; Dario C Altieri; Sebastien Bonnet; Alois Haromy; Gwyneth Harry; Sandra Bonnet; Lakshmi Puttagunta; Evangelos D Michelakis
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

5.  Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.

Authors:  Masahiko Oka; Noriyuki Homma; Laimute Taraseviciene-Stewart; Kenneth G Morris; Donatas Kraskauskas; Nana Burns; Norbert F Voelkel; Ivan F McMurtry
Journal:  Circ Res       Date:  2007-03-01       Impact factor: 17.367

6.  Vascular smooth muscle cell phenotypes in primary pulmonary hypertension.

Authors:  Y Mitani; M Ueda; R Komatsu; K Maruyama; R Nagai; M Matsumura; M Sakurai
Journal:  Eur Respir J       Date:  2001-02       Impact factor: 16.671

7.  Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation.

Authors:  Noriyuki Homma; Tetsutaro Nagaoka; Yoshiteru Morio; Hiroki Ota; Sarah A Gebb; Vijaya Karoor; Ivan F McMurtry; Masahiko Oka
Journal:  J Cardiovasc Pharmacol       Date:  2007-12       Impact factor: 3.105

Review 8.  Endothelium-derived hyperpolarizing factor: where are we now?

Authors:  Michel Félétou; Paul M Vanhoutte
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-16       Impact factor: 8.311

Review 9.  Role of reactive oxygen species in chronic hypoxia-induced pulmonary hypertension and vascular remodeling.

Authors:  Eva Nozik-Grayck; Kurt R Stenmark
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

10.  Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats.

Authors:  M N Gillespie; J W Olson; C N Reinsel; W N O'Connor; R J Altiere
Journal:  Am J Physiol       Date:  1986-07
View more
  9 in total

Review 1.  Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies.

Authors:  Helen Christou; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-25       Impact factor: 4.733

2.  Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models.

Authors:  Changlei Bao; Qian He; Hui Wang; Yanan Sun; Yahang Xu; Yan Pan; Yadan Hu; Shichuang Zheng; Shuxin Liang; Ang Luo; Tanzilan Nahar; Jiwang Chen; Haiyang Tang; Ying Han
Journal:  Oxid Med Cell Longev       Date:  2022-06-17       Impact factor: 7.310

3.  Puerarin-V prevents the progression of hypoxia- and monocrotaline-induced pulmonary hypertension in rodent models.

Authors:  Di Chen; Hui-Fang Zhang; Tian-Yi Yuan; Shu-Chan Sun; Ran-Ran Wang; Shou-Bao Wang; Lian-Hua Fang; Yang Lyu; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2022-02-21       Impact factor: 7.169

4.  Influence of riociguat treatment on pulmonary arterial hypertension : A meta-analysis of randomized controlled trials.

Authors:  R Zhao; Y Jiang
Journal:  Herz       Date:  2018-07-10       Impact factor: 1.443

5.  Carbonic anhydrase inhibition improves pulmonary artery reactivity and nitric oxide-mediated relaxation in sugen-hypoxia model of pulmonary hypertension.

Authors:  Helen Christou; Zoe Michael; Fotios Spyropoulos; Yunfei Chen; Dan Rong; Raouf A Khalil
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-04-07       Impact factor: 3.210

6.  Noninvasive detection of impaired pulmonary artery endothelial function in people living with HIV.

Authors:  Erin Goerlich; Monica Mukherjee; Michael Schar; Todd T Brown; Gabriele Bonanno; Robert G Weiss; Allison G Hays
Journal:  AIDS       Date:  2020-12-01       Impact factor: 4.632

7.  Chronic Hypoxia Decreases Endothelial Connexin 40, Attenuates Endothelium-Dependent Hyperpolarization-Mediated Relaxation in Small Distal Pulmonary Arteries, and Leads to Pulmonary Hypertension.

Authors:  Rui Si; Qian Zhang; Jody Tori O Cabrera; Qiuyu Zheng; Atsumi Tsuji-Hosokawa; Makiko Watanabe; Susumu Hosokawa; Mingmei Xiong; Pritesh P Jain; Anthony W Ashton; Jason X-J Yuan; Jian Wang; Ayako Makino
Journal:  J Am Heart Assoc       Date:  2020-12-12       Impact factor: 5.501

8.  Adipokines and Metabolic Regulators in Human and Experimental Pulmonary Arterial Hypertension.

Authors:  Aimilia Eirini Papathanasiou; Fotios Spyropoulos; Zoe Michael; Kyoung E Joung; Despina D Briana; Ariadne Malamitsi-Puchner; Christos S Mantzoros; Helen Christou
Journal:  Int J Mol Sci       Date:  2021-02-01       Impact factor: 5.923

9.  Evidence supporting a role for circulating macrophages in the regression of vascular remodeling following sub-chronic exposure to hemoglobin plus hypoxia.

Authors:  Vijaya Karoor; Delaney Swindle; David I Pak; Derek Strassheim; Mehdi A Fini; Edward Dempsey; Kurt R Stenmark; Kathryn Hassell; Rachelle Nuss; Paul W Buehler; David C Irwin
Journal:  Pulm Circ       Date:  2021-11-05       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.